CasLoc logo
All Cases PTAB Litigations UPC Oppositions

SANOFI-AVENTIS U.S. LLC v. FRESENIUS KABI USA, LLC

3:14-cv-08082

Overview

Case Number 3:14-cv-08082
Filing Date 2014-12-29
Status Terminated
Termination Date 2017-09-26
Court District Court, D. New Jersey (njd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:145 Patent Infringement
Jury Demand None

Parties

Defendant

FRESENIUS KABI USA, LLC Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

SANOFI-AVENTIS U.S. LLC Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. New Jersey (njd)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 3 proceedings
πŸ›οΈ
USPTO PTAB Trials 3 proceedings
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): FR πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (6 found):
PTAB: 3 U.S. Courts: 3
USPTO PTAB Trial 2018-10-31
IPR2019-00136

Neptune Generics, LLC et al. v. Aventis Pharma S.A. et al.

U.S. Continuation Sibling (5847170)
Status: Institution Denied
USPTO PTAB Trial 2016-03-15
IPR2016-00712

Mylan Laboratories Limited et al. v. AVENTIS PHARMA S.A. et al.

U.S. Continuation Sibling (8927592)
Status: Final Written Decision
USPTO PTAB Trial 2016-02-17
IPR2016-00627

Mylan Laboratories Limited et al. v. Aventis Pharma S.A. et al.

U.S. Continuation Sibling (5847170)
Status: Institution Denied
U.S. District Court 2015-01-15
1:15-cv-00044

Sanofi-Aventis U.S. LLC v. Apotex Corp.

Asserted Patent
Status: DED
U.S. District Court 2014-12-30
1:14-cv-01533

Sanofi-Aventis U.S. LLC v. Fresenius Kabi USA LLC

Asserted Patent
Status: DED
U.S. District Court 2014-12-29
3:14-cv-08079

SANOFI-AVENTIS U.S. LLC v. ACCORD HEALTHCARE, INC.

Asserted Patent
Status: NJD
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7241907
Acetone solvate of dimethoxy docetaxel and its process of preparation
Filed: 2004-09-17
Issued: 2007-07-10
Expired (Term Ended) +449d PTA
Expires: 2025-12-10
US8927592
Antitumoral use of cabazitaxel
Filed: 2012-04-26
Issued: 2015-01-06
Active (5.4 yrs remaining)
Expires: 2032-04-26
US5847170
Taxoids, their preparation and pharmaceutical compositions containing them
Filed: 1996-03-26
Issued: 1998-12-08
Expired (Term Ended) +1826d PTA
Expires: 2021-03-26

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+449 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

4

Dispositive

0

Granted

0

Denied

0

Pending / Review

3

Motions by Category

Claim Construction / Markman Filing 2 Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
TEXT ORDER: Counsel shall disregard the September 22, 2016 claim construction Memorandum Opinion and accompanying Order. By September 29, 2016, the Court shall ...
Entry #54 • 2016-09-26 Document →
Procedural / Extension Motion Pending
Set Deadlines as to 38 MOTION for Leave to Appear Pro Hac Vice . Motion set for 12/21/2015 before Magistrate Judge Lois H. Goodman. The motion will be decided o...
Entry #β€” • 2015-11-23
Procedural / Extension Motion Pending / Under Review
MOTION for Leave to Appear Pro Hac Vice by AVENTIS PHARMA S.A., SANOFI, SANOFI-AVENTIS U.S. LLC. (Attachments: # 1 Certification of William E. Solander, # 2 Cer...
Entry #38 • 2015-11-20 Document →
Claim Construction / Markman Filing Pending / Under Review
PRETRIAL SCHEDULING ORDER. Telephone Status Conference set for 8/18/2015 at 11:00 AM before Magistrate Judge Lois H. Goodman; Markman Hearing set for 2/23/2016;...
Entry #23 • 2015-06-12 Document →

Docket Entries

(83 total)
Pleading / Complaint

COMPLAINT against FRESENIUS KABI USA, LLC (Filing and Admin fee $400 receipt number 0312-6124254), filed by SANOFI-AVENTIS U.S. LLC, AVENTIS PHARMA S.A., SANOFI. (Attachments: # 1 Civil Cover Sheet)(mmh) (Entered: 12/30/2014)

Entry #1 • 2014-12-29
1
Pleading / Complaint

COMPLAINT against FRESENIUS KABI USA, LLC (Filing and Admin fee $400 receipt number 0312-6124254), filed by SANOFI-AVENTIS U.S. LLC, AVENTIS PHARMA S.A., SANOFI. (Attachments: # 1 Civil Cover Sheet)(mmh) (Entered: 12/30/2014)

Entry #1 • 2014-12-29
2

Corporate Disclosure Statement by AVENTIS PHARMA S.A., SANOFI, SANOFI-AVENTIS U.S. LLC. (mmh) (Entered: 12/30/2014)

Entry #2 • 2014-12-29
1

AO120 Patent/Trademark Form filed. (mmh) (Entered: 12/30/2014)

Entry #3 • 2014-12-29
1

SUMMONS ISSUED as to FRESENIUS KABI USA, LLC Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. Issued By *Melissa M. Haneke* (mmh) (Entered: 12/30/2014)

Entry #4 • 2014-12-30
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc